Drug
Encaleret
Encaleret is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (75.0%)
Phase 31 (25.0%)
Trials by Status
active_not_recruiting125%
completed250%
recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruitingphase_3
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
NCT05680818
recruitingphase_2
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
NCT07080385
completedphase_2
PTH-independent Effects of Encaleret
NCT05735015
completedphase_2
Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1
NCT04581629
Clinical Trials (4)
Showing 4 of 4 trials
NCT05680818Phase 3
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
NCT07080385Phase 2
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
NCT05735015Phase 2
PTH-independent Effects of Encaleret
NCT04581629Phase 2
Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4